Prognosis
Eli Lilly Joins Race to Develop Coronavirus Treatment
- Lilly close to Covid-19 partnership with AbCellera Biologics
- Drugmakers are hustling to develop treatments, vaccines
This article is for subscribers only.
Pharmaceutical giant Eli Lilly & Co. has entered an agreement to develop an experimental therapy for the new coronavirus with with closely held biotechnology company AbCellera Biologics Inc.
The Vancouver based biotechnology firm is already working on discovering antibodies that could potentially be deployed to stop transmission of the virus and prevent the lung illness known as Covid-19.